Skip to main content

Table 2 In vitro antifungal susceptibility test results of Candida species

From: Evaluation of candidemia in epidemiology and risk factors among cancer patients in a cancer center of China: an 8-year case-control study

Candida species Strains (n) Antifungal agent MIC Range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml) No. (%) of susceptibility
C.albicans 44 Flucytosine <=4–16 <=4 <=4 42(95.5%)
44 Amphotericin B <=0.5–1 <=0.5 1 ND
44 Fluconazole <=1–16 <=1 2 43(97.7%)
44 Itraconazole <=0.125–0.25 <=0.125 <=0.125 43(97.7%)
44 Voriconazole <=0.06–1 <=0.06 0.25 44(100%)
C.parapsilosis complex 17 Flucytosine <=4 <=4 <=4 17(100%)
17 Amphotericin B <=0.5–1 <=0.5 <=0.5 ND
17 Fluconazole <=1–2 1 1 17(100%)
17 Itraconazole <=0.125 <=0.125 <=0.125 17(100%)
17 Voriconazole <=0.06–0.5 <=0.06 0.5 17(100%)
C.tropicalis 7 Flucytosine <=4 <=4 <=4 7(100%)
7 Amphotericin B <=0.5 <=0.5 <=0.5 ND
7 Fluconazole <=1–8 <=1 4 7(100%)
7 Itraconazole <=0.125 <=0.125 <=0.125 7(100%)
7 Voriconazole <=0.06–0.5 0.12 0.5 7(100%)
C.glabrata complex 6 Flucytosine <=4 <=4 <=4 6(100%)
6 Amphotericin B <=0.5 <=0.5 <=0.5 ND
6 Fluconazole 4–8 8 16 5(83.3%)
6 Itraconazole 0.125–0.5 0.25 0.5 3(50%)
6 Voriconazole <=0.06–0.5 0.25 0.5 6(100%)
C.lusitaniae 3 Flucytosine <=4 <=4 <=4 3(100%)
3 Amphotericin B <=0.5 <=0.5 <=0.5 ND
3 Fluconazole <=1 <=1 <=1 3(100%)
3 Itraconazole <=0.125 <=0.125 <=0.125 3(100%)
3 Voriconazole <=0.06 <=0.06 <=0.06 3(100%)
C.famata 3 Flucytosine <=4 <=4 <=4 3(100%)
3 Amphotericin B <=0.5 <=0.5 <=0.5 ND
3 Fluconazole <=1 <=1 <=1 3(100%)
3 Itraconazole <=0.125 <=0.125 <=0.125 3(100%)
3 Voriconazole <=0.06–0.12 <=0.06 0.12 3(100%)
  1. NA Not Defined